What is Remicade?
Remicade is an advanced, FDA- approved medication that has been clinically proven to reduce the painful symptoms of a number of inflammatory disorders involving the immune system.
Remicade reduces the signs and symptoms of Crohn’s Disease and Ulcerative Colitis and has been shown to achieve remission (periods of no symptoms or very few symptoms) in people with moderate to severe (IBD) Inflammatory Bowel Disease, who have not responded well to other therapies. While Remicade will not cure IBD, it is proven to help many people get real control over their symptoms. In addition to helping control symptoms, ongoing regular therapy with Remicade has actually been shown to heal the damage to the intestinal lining caused by IBD.
How does Remicade work?
Remicade works with your immune system to put your disease into remission (a dormant state) and keep it there. Remicade blocks a protein made by your immune system called tumor necrosis factor or TNF-Alpha. People with certain diseases have too much TNF-Alpha, which confuses the immune system. This can cause it to attack normal healthy tissue and not just foreign substances. Too much TNF-Alpha causes inflammation, swelling and discomfort in the healthy tissue that gets attacked. Remicade targets TNF-Alpha and blocks the damage caused by too much TNF-Alpha. This reduces inflammation and puts your autoimmune disease into remission.
How do I take Remicade?
Remicade is given by intravenous (IV) infusion. This means that it is given as an injection through a needle that is placed into your vein. Remicade must be injected slowly over a period of at least 2 hours. A healthcare professional administers the treatment in a supervised environment, which is either the office or a treatment center. You will receive your first dose followed by additional doses at two and six weeks after the first dose. You will then receive a dose every eight weeks. Your healthcare professional will carefully calculate the dosage customized to your weight so that you get the best response to the treatment.